Facebook
Twitter
Telegram
Report an ErrorCassava Sciences Balance Sheet 2011-2024 | SAVA
Annual Balance Sheet Cassava Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-201 M | -233 M | -93.2 M | -23 M | -19.8 M | -10.5 M | -16.6 M | -31.3 M | -40.6 M | -48.6 M | -49.4 M | -73.1 M | |
Long Term Debt |
- | 35 K | 139 K | 235 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | 104 K | 97 K | 58 K | 90 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | 33.7 M | 41.3 M |
Total Current Liabilities |
14.2 M | 7.06 M | 12.5 M | 1.86 M | 1.39 M | 511 K | 1.13 M | 665 K | 2.55 M | 850 K | 1.8 M | 10 M | 13.3 M |
Total Liabilities |
14.2 M | 7.3 M | 12.9 M | 2.1 M | 1.39 M | 511 K | 1.13 M | 665 K | 2.55 M | 850 K | 1.8 M | 43.7 M | 54.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 7.83 M | 10.9 M |
Retained Earnings |
-381 M | -284 M | -207 M | - | -169 M | -164 M | -157 M | -145 M | -131 M | -116 M | -104 M | -136 M | -132 M |
Total Assets |
152 M | 235 M | 267 M | 94.3 M | 23.5 M | 20.1 M | 10.8 M | 19.3 M | 31.9 M | 40.9 M | 50.1 M | 56.9 M | 99 M |
Cash and Cash Equivalents |
121 M | 201 M | 233 M | 93.5 M | 23.1 M | 19.8 M | 10.5 M | 16.6 M | 31.3 M | 40.6 M | 48.6 M | 49.4 M | 73.1 M |
Book Value |
137 M | 228 M | 254 M | 92.2 M | 22.1 M | 19.6 M | 9.7 M | 18.6 M | 29.4 M | 40.1 M | 48.3 M | 13.1 M | 44.4 M |
Total Shareholders Equity |
137 M | 228 M | 254 M | 92.2 M | 22.1 M | 19.6 M | 9.7 M | 18.6 M | 29.4 M | 40.1 M | 48.3 M | 13.1 M | 44.4 M |
All numbers in USD currency
Quarterly Balance Sheet Cassava Sciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 35 K | 62 K | - | 114 K | 139 K | 164 K | 188 K | 213 K | 235 K | 235 K | 235 K | 235 K | - | 23 K | 45 K | 68 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
17.4 M | 17.9 M | 14.1 M | 7.3 M | 8.57 M | - | 7.1 M | 12.9 M | 6.68 M | 4.82 M | 2.86 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 511 K | 511 K | 511 K | 511 K | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 665 K | 665 K | 665 K | 665 K | 2.55 M | 2.55 M | 2.55 M | 2.55 M | 850 K | 850 K | 850 K | 850 K | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.83 M | 7.83 M | 7.83 M | 7.83 M | 7.83 M | 7.83 M | 7.83 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M |
Retained Earnings |
-360 M | -334 M | -308 M | -284 M | -264 M | - | -225 M | -207 M | -193 M | -184 M | -178 M | -175 M | -175 M | -175 M | -175 M | -169 M | -169 M | -169 M | -169 M | -164 M | -164 M | -164 M | -164 M | -157 M | -157 M | -157 M | -157 M | -145 M | -145 M | -145 M | -145 M | -131 M | -131 M | -131 M | -131 M | -116 M | -116 M | -116 M | -116 M | -104 M | -104 M | -104 M | -104 M | -136 M | -136 M | -136 M | -136 M | -132 M | -132 M | -132 M | -132 M |
Total Assets |
173 M | 197 M | 218 M | 235 M | 207 M | - | 244 M | 267 M | 274 M | 281 M | 284 M | 94.3 M | 94.3 M | 94.3 M | 94.3 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 31.9 M | 31.9 M | 31.9 M | 31.9 M | 40.9 M | 40.9 M | 40.9 M | 40.9 M | 50.1 M | 50.1 M | 50.1 M | 50.1 M | 56.9 M | 56.9 M | 56.9 M | 56.9 M | 99 M | 99 M | 99 M | 99 M |
Cash and Cash Equivalents |
142 M | 168 M | 187 M | 201 M | 175 M | 197 M | 210 M | 233 M | 242 M | 278 M | 282 M | 93.5 M | 93.5 M | 93.5 M | 93.5 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 40.6 M | 40.6 M | 40.6 M | 40.6 M | 48.6 M | 48.6 M | 48.6 M | 48.6 M | 49.4 M | 49.4 M | 49.4 M | 49.4 M | 73.1 M | 73.1 M | 73.1 M | 73.1 M |
Book Value |
155 M | 179 M | 204 M | 228 M | 199 M | - | 237 M | 254 M | 268 M | 276 M | 281 M | 92.2 M | 92.2 M | 92.2 M | 92.2 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 40.1 M | 40.1 M | 40.1 M | 40.1 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M |
Total Shareholders Equity |
155 M | 179 M | 204 M | 228 M | 199 M | 218 M | 237 M | 254 M | 268 M | 276 M | 281 M | 92.2 M | 92.2 M | 92.2 M | 92.2 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 40.1 M | 40.1 M | 40.1 M | 40.1 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M |
All numbers in USD currency